Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Trio raises combined $160.7M in follow-ons

A trio of biotechs raised a combined $160.7 million in follow-ons on Wednesday. Insmed Inc. (NASDAQ:INSM) raised $62.4 million through the sale of 6 million shares

Read the full 269 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE